Applied Therapeutics, Inc. (APLT) NASDAQ

1.02

+0.02(+2.00%)

Updated at October 06 03:50PM

Currency In USD

Valuation

Market Cap119.47M
Enterprise Value42.87M
P/E Ratio-2.41
PEG Ratio0.65
Price/Sales Ratio1,327.98
Price/Book Ratio9.36
Enterprise/Revenue1,099.96
Enterprise/EBITDA-1.21

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-555.24
Operating Margin-913.02

Management Effectiveness

Return On Assets-1.81
Return On Equity-2.32

Income Statement

Revenue455,000
Revenue/Share0
Gross Profit455,000
EBITDA-103.87M
Net Income-105.62M
Diluted EPS-0.76

Balance Sheet

Total Cash30.42M
Total Cash/Share0.21
Total Debt2.6M
Total Debt/Equity0.15
Current Ratio1.94
Book Value Per Share0.12

Price History

52-Week Change-85.39
52-Week High10.62
52-Week Low0.3
Moving Average 50 Days0.51
Moving Average 200 Days0.51

Statistics

Average Volume4.36M
Shares Outstanding144.01M
% Held by Institutions59.43

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A